A series of 13 patients is described to demonstrate the experience of the authors with free-tissue transfer for limb salvage in patients with purpura fulminans. A total of seven free-flap procedures were performed, with a loss of flap in one patient. The flaps were used for lower-extremity salvage in six patients and for upper-extremity salvage in one. Purpura fulminans is a devastating illness caused by endotoxin-producing bacteria such as meningococcus and pneumococcus. Clotting derangements and systemic vasculitis often lead to widespread tissue necrosis in the extremities. Local tissue is usually not available to cover vital structures in these complex wounds. In these situations, free-tissue transfer is necessary to achieve limb salvage. Microsurgical reconstruction in patients with purpura fulminans is a formidable challenge. Because of high platelet counts and systemic vasculitis, successful microvascular anastomosis is difficult. Abnormally high platelet counts persist well into the subacute and chronic phases of the illness. Pretreatment with antiplatelet agents before microvascular surgery may be beneficial. The systemic nature of the vascular injury does not permit microvascular anastomosis to be performed outside the "zone of injury." Extensive vascular exposure, even at a great distance from the wound, does not reveal a disease-free vessel. The friable intima is difficult to manage with a standard end-to-side anastomosis, but conversion to end-toend anastomosis may salvage free-tissue transfers in cases in which intimal damage is too severe to sustain a patent anastomosis. Patients often have peripheral neuropathies caused by the underlying disease; however, this resolves with time and is not a contraindication to limb salvage. (Plast. Reconstr. Surg. 107: 1437 Surg. 107: , 2001 Purpura fulminans is a devastating illness consisting of rapidly progressive skin and softtissue hemorrhage and necrosis due to dermal vascular thrombosis and disseminated intravascular coagulation. The underlying cause is usually an acute septic illness with an endotoxinproducing lipopolysaccharide bacterium such as Neisseria meningitidis. Purpura fulminans occurs in 15 to 25 percent of meningococcemia cases, and most centers report mortality rates of 20 to 60 percent. 1 Purpuric lesions and tissue necrosis are the hallmarks of purpura fulminans. Bacterial lipopolysaccharide leads to tissue necrosis through a triad of mechanisms, including hemorrhage, disseminated intravascular coagulation, and shock. Hemorrhagic necrosis of skin and subcutaneous tissues can extend to involve underlying muscle and bone. Extremities are most severely affected in purpura fulminans, and involvement is often symmetrical (Fig. 1, left) . A large percentage of patients in most series require one or more amputations, [2] [3] [4] [5] [6] and limb salvage or preservation of limb length can make a significant difference in functional status and quality of life. Microsurgical reconstruction in the face of purpura fulminansinduced vasculitis poses a formidable challenge to the reconstructive surgeon. The current literature on purpura fulminans focuses mainly on medical management, and there is little information, if any, about limb salvage in this disease. In this study, we sought to identify the issues associated with microsurgical limb salvage in the purpura fulminans patient and to propose suggestions for management.
PATIENTS AND METHODS
The records of patients admitted over the years 1986 to 1999 were retrospectively reviewed at our institutions, and 13 patients with purpura fulminans were identified. Of the 13, five had limb-threatening disease requiring 
RESULTS
A total of four adults and nine children, including one neonate, had a diagnosis of purpura fulminans. Two adults had previously had splenectomies. Two patients (15 percent) died of their disease. One child with a very mild form of the disease did not require surgical intervention. The remaining 10 patients required skin grafting and seven also had finger, toe, or extremity amputations. Of the 10 patients, three went on to require four extremity amputations. Five surviving patients had at least one extremity that could not be salvaged with skin grafts or local flaps, and free-tissue transfer was required for limb salvage.
Five patients underwent a total of seven freetissue transfers (Table I) . One patient required microsurgical reconstruction of both lower extremities, and one had a flap failure necessitating a second free-tissue transfer to the same extremity. The seven procedures included four latissimus dorsi flaps, one rectus abdominis flap, one gracilis flap, and one lateral arm flap.
One patient had both a flap failure and a flap complication (hematoma).
No flap procedures were performed in the acute septic phase of the illness. Four patients underwent microvascular reconstruction at approximately 1 month after the onset of the illness. One patient with chronic wounds of both legs underwent reconstructive procedures at 4 and 7 months.
Anastomotic problems were common. In four patients, flaps that were initially anastomosed end-to-side into the posterior tibial artery required conversion to end-to-end anastomosis due to friable vessels and intraoperative thrombosis. In one patient, a flap anastomosed end-to-side into the femoral artery eventually failed.
Platelet counts were high or high normal in all patients at the time of free-tissue transfer (range, 301,000 to 934,000). Normal range at our institution is 145,000 to 350,000. A variety of anticoagulants were used. All patients were given acetylsalicylic acid postoperatively. The most recently treated patient received acetylsalicylic acid both preoperatively and postoperatively. Additional anticoagulants used were systemic heparin in two patients and lowmolecular weight dextran, enoxaparin sodium (Lovenox), and subcutaneous heparin in one patient each. Mean length of follow-up was 60 months (range, 24 to 103 months). Four patients with five lower-extremity flaps are ambulatory in regular shoes or with prostheses. One patient with a lateral arm flap to the hand is independent with activities of daily living, despite a contralateral below-elbow amputation.
CASE REPORTS

Case 1
A 3 1 ⁄2-year-old boy was admitted with meningococcemia and purpura fulminans involving the lower extremities symmetrically ( Fig. 1, left) . Both knee joints became exposed (Fig.  1, right) . The left side was managed with a gastrocnemius muscle flap, but local tissue was unavailable on the right side, and a free latissimus dorsi muscle flap procedure was done. Patchy necrosis of the flap over a 2-week period necessitated a second free-flap with rectus abdominis muscle to salvage the leg. Poor quality of the recipient vessel led to revision of the arterial anastomosis from end-to-side (the posterior tibial artery) to end-to-end. Additional postoperative complications included a hematoma requiring drainage on the first postoperative day and a septic joint requiring elevation of the flap for drainage. Two years later, the patient is walking well and continues to work on range of motion (Fig. 2) .
Case 2
A 5-year-old boy was admitted with meningococcemia and purpura fulminans (Fig. 3, above) . He required bilateral below-elbow amputations. Despite lower-extremity fasciotomies, he required a right above-knee amputation and a high left below-knee amputation (Fig. 3, center) . To prevent revision to an above-knee level, the left stump was resurfaced with a free latissimus dorsi muscle flap and skin graft. Five years later, the patient is ambulatory on prostheses and has stable and durable coverage of the left stump (Figs. 3, below, and Fig. 4 ).
DISCUSSION
The pathophysiology of purpura fulminans involves endothelial damage caused by bacterial lipopolysaccharide. Endothelial damage leads to cutaneous hemorrhage, and low levels of proteins C and S lead to disseminated intravascular coagulation. Acute shock and a low flow state contribute to tissue necrosis. 2 The causes of purpura fulminans include inherited protein C or protein S deficiency (neonatal purpura fulminans), idiopathic purpura fulminans following a benign viral infection, and acute infectious purpura fulminans. All pa- 9,10 Likewise, we do not use corticosteroids in the acute management of these patients. There are anecdotal reports of improvement in purpuric lesions with such varied treatments as hyperbaric oxygen, 11 sympathetic blockade, 12 topical nitroglycerin, 13 and leeches, 14 although none of these modalities is currently in use at our institutions. Prospective randomized trials are being done to investigate the efficacy of protein C and antithrombin III in purpura fulminans.
Early detection of elevated compartment pressures may be helpful in minimizing tissue necrosis in the extremities. Fasciotomy is not expected to halt progression of the disease, but may help preserve viable tissue and serve as a diagnostic tool. Staged debridement and grafting are the next steps in reconstruction. Devascularized limbs are allowed to demarcate before amputation to preserve maximum limb length, and later revision to a higher amputa- tion level is common. Several authors have advocated the use of magnetic resonance imaging before amputation for delineating viable muscle and bone, 3, 15 although we have no experience with this technique.
Purpura fulminans affects extremities more severely than the trunk, and many patients have four-limb involvement. Salvage of even one limb can make a significant difference in functional status and quality of life. Local tissue is often unavailable for reconstructive purposes, and we have found free-tissue transfer to be a valuable tool in limb salvage.
Of seven free-tissue transfer procedures in this series, six were needed to cover lowerextremity wounds. Three flaps were used for distal tibial wounds, one for an open knee joint, and one to preserve length on a high open below-knee amputation stump to prevent revision to an above-knee amputation. The single upper-extremity flap in this series prevented revision of the amputation to a higher level and gave stable coverage to functional phalangeal remnants.
Three patients with four salvaged lower extremities reported numbness of the plantar aspect of the foot during the acute illness and reconstruction. All three regained at least protective sensation. Pathologic specimens from debridements have shown inflammation of nerves in purpura fulminans-involved areas, suggesting neuritis as the etiology of the neuropathy. Although absence of plantar sensation can be a contraindication to foot salvage in the trauma population, purpura fulminans patients have a better prognosis for nerve recovery, and plantar numbness is not a contraindication to limb salvage. Microvascular surgery in the purpura fulminans patient is technically challenging. The vessels are friable and have severe intimal injury. It is difficult to get out of the "zone of injury" caused by widespread vasculitis. Even a microvascular clamp may further damage the intima and contribute to thrombosis. The disease affects the extremities more severely than the trunk and, although recipient vessels are severely diseased, the rectus and latissimus muscles and their vascular pedicles are relatively spared. Our single experiences with the lateral arm flap and with the gracilis muscle also revealed relatively healthy flap vessels.
Intraoperative anastomotic complications are common. Four lower-extremity flaps initially anastomosed to the posterior tibial artery in an end-to-side fashion had intraoperative thrombosis. Each required revision to end-toend anastomosis for successful revascularization. End-to-end anastomosis may allow better control of the damaged intima. Systemic heparin before vessel clamping was not routinely used except in cases of intraoperative thrombosis requiring revision. Patients did not routinely undergo preoperative arteriography, because it does not identify the intimal disease and contributes little to preoperative planning unless there is a history of previous trauma or disease. However, it is important to clinically demonstrate adequate arterial inflow to the foot before using the posterior tibial artery in an end-to-end fashion.
Although platelet counts are perilously low in the acute phase of purpura fulminans, bone marrow rebound in the recovery phase leads to platelet counts that are well above normal at the time of extremity reconstruction. High platelet counts combined with endothelial damage from vasculitis create a difficult milieu for microvascular surgery. It is helpful to have an accurate picture of preoperative platelet function in these patients and, although high platelet counts are not a contraindication to microsurgery, preoperative and postoperative anti-platelet agents may be beneficial.
The timing of microvascular limb salvage in the patient with purpura fulminans depends largely on the patient's medical status. Four of our patients underwent surgery for free flaps 1 month after the onset of the disease, allowing for medical stabilization and final demarcation of nonviable tissue before definitive treatment. One patient with wounds of a more chronic nature and pathologic fractures underwent surgery for free flaps at 4 and 7 months after disease onset. Even at 7 months, thrombocytosis persisted and the effects of vasculitis were readily apparent in the friable posterior tibial arteries in this patient.
Free-tissue transfer is a useful tool for limb salvage in patients with purpura fulminans. Systemic derangements in clotting factors and vessel inflammation make this a technically demanding procedure. All five of our patients with limb salvage are functionally improved. Four patients with limb salvage of the lower extremity are walking in regular shoes or on prosthetic limbs, and the single upper-extremity patient lives independently despite the loss of three other limbs. 
